ID   CHO AM-1/D
AC   CVCL_D3W2
SY   AM-1/D CHO; AM-1/D; AM-1/cyclin D CHO
DR   Wikidata; Q127380462
RX   Patent=US6210924;
CC   Group: Patented cell line.
CC   Group: Serum/protein free medium cell line.
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; UniProtKB; Q2MH30; Dhfr; Simple; p.Thr137Arg (c.410G>C); Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:1582; CCND1.
CC   Genetic integration: Method=Transfection; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Transformant: ChEBI; CHEBI_23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Transformant: NCIt; C44386; Gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_D3W1 ! CHO AM-1
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 30-01-24; Last updated: 19-12-24; Version: 3
//
RX   Patent=US6210924;
RA   Hu S.-F.S., Gudas J.M., Brankow D.W.;
RT   "Overexpressing cyclin D 1 in a eukaryotic cell line.";
RL   Patent number US6210924, 03-Apr-2001.
//